Treatment-modifications to CI speech processor program for To Improve Speech Understanding in Noise and Localization in SSD-CI Recipients
Phase-Based Progress Estimates
Effectiveness
Safety
Washington University School of Medicine, Saint Louis, MO
To Improve Speech Understanding in Noise and Localization in SSD-CI Recipients
Treatment-modifications to CI speech processor program - DeviceEligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
Interaural loudness and pitch mismatch in SSD-CI recipients reduces binaural processing cues and contributes to performance outcomes, specifically speech understanding in noise and localization. We aim to improve binaural cues through speech processor program modifications that reduce interaural mismatches.
Treatment Effectiveness
Effectiveness Progress
Other trials for To Improve Speech Understanding in Noise and Localization in SSD-CI Recipients
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 6 months
6 months
Speech understanding in noise
Trial Safety
Safety Progress
Other trials for To Improve Speech Understanding in Noise and Localization in SSD-CI Recipients
Trial Design
1 Treatment Group
Single arm
1 of 1
Experimental Treatment
50 Total Participants · 1 Treatment Group
Primary Treatment: Treatment-modifications to CI speech processor program · No Placebo Group · N/A
Single arm
Device
Experimental Group · 1 Intervention: Treatment-modifications to CI speech processor program · Intervention Types: DeviceTrial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months
Closest Location: Washington University School of Medicine · Saint Louis, MO
2004First Recorded Clinical Trial
1 TrialsResearching To Improve Speech Understanding in Noise and Localization in SSD-CI Recipients
1474 CompletedClinical Trials
Who is running the clinical trial?
Washington University School of MedicineLead Sponsor
1,772 Previous Clinical Trials
2,270,631 Total Patients Enrolled
CochlearIndustry Sponsor
77 Previous Clinical Trials
5,670 Total Patients Enrolled
Eligibility Criteria
Age 18+ · All Participants · 6 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:You have a hearing loss in your better ear that is at least 30 dB HL in the contralateral ear.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments